Similar Posts
Refusal to prescribe EC in Italy met with legal action
In contrast to the stories of EC refusal we’ve been hearing about in Poland, recent stories of EC refusal in Italy have been met with legal action and consequences. In the province of Pavia, a nurse has resigned following an investigation by the hospital she worked at into why she denied EC access to two…
Spain: EC use drops due to the pandemic
July 2021. According to the Spanish Society of Contraception (SEC), use of emergency contraception pills dropped among women aged 25 to 30 and 35 to 40, from 38% to 2,7. Read more here:
FIGO recommends promoting and suppling emergency contraception, during the COVID-19 pandemic
May 2020. Last April, the International Federation of Gynecology and Obstetrics (FIGO) issued a statement pointing at key action points to ensure access to contraception services and supplies during the COVID-19 pandemic. Contraception services and supplies are core components of essential health services and access to these is a fundamental human right. The key action…
Self-care interventions: guidance for health systems.
July 2024. The World Health Organization (WHO)/HRP just published Implementation of self-care interventions for health and well-being: guidance for health systems. Aimed at those around the world implementing self-care interventions, the publication reviews WHO’s six health systems building blocks, and looks at the implementation considerations necessary for each. Several country case studies are also included….
November 25: International Day for the Elimination of Violence against Women
According to the WHO report Global and regional estimates of violence against women, 25% of women in the European Region experience physical and/or sexual violence by intimate partners at some point of their life, and 5% experience sexual violence from people who are not their partners. On the International Day for the Elimination of Violence…
LNG and UPA remain suitable EC options for all, EMA concludes
The European Medicines Agency (EMA) released the following statement today: “The European Medicines Agency has concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate to assess whether increased bodyweight affects the effectiveness of these medicines in preventing unintended pregnancy following unprotected sexual intercourse or contraceptive failure. The Agency’s Committee for Medicinal Products for Human…